Citation Tools

Original article
A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis

Download to a citation manager

Cite this article as:
Rutgeerts PJ, Fedorak RN, Hommes DW, et al
A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis